Total Payments
$10,209
2024 Payments
$135.03
Companies
18
Transactions
149
Medicare Patients
3,236
Medicare Billing
$461,681
Payment Breakdown by Category
Other$6,000 (58.8%)
Food & Beverage$2,848 (27.9%)
Education$860.32 (8.4%)
Consulting$500.00 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,000 | 3 | 58.8% |
| Food and Beverage | $2,848 | 124 | 27.9% |
| Education | $860.32 | 21 | 8.4% |
| Consulting Fee | $500.00 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theravance Biopharma, Inc. | $6,957 | 16 | $0 (2018) |
| Astellas Pharma US Inc | $792.16 | 28 | $0 (2024) |
| Insmed, Inc. | $454.88 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $440.68 | 26 | $0 (2023) |
| Gilead Sciences, Inc. | $345.04 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $290.31 | 18 | $0 (2021) |
| Melinta Therapeutics, LLC | $205.04 | 5 | $0 (2020) |
| Janssen Products, LP | $178.33 | 3 | $0 (2021) |
| ViiV Healthcare Company | $173.36 | 10 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $76.94 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.03 | 7 | PFIZER INC. ($36.91) |
| 2023 | $348.65 | 11 | Insmed, Inc. ($239.20) |
| 2022 | $248.28 | 12 | Astellas Pharma US Inc ($124.91) |
| 2021 | $299.99 | 11 | Insmed, Inc. ($116.37) |
| 2020 | $365.67 | 15 | Astellas Pharma US Inc ($145.94) |
| 2019 | $581.96 | 21 | Astellas Pharma US Inc ($196.53) |
| 2018 | $4,897 | 35 | Theravance Biopharma, Inc. ($4,279) |
| 2017 | $3,332 | 37 | Theravance Biopharma Inc. ($2,678) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINES | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Infectious Diseases | ||||||
| 04/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: VACCINES | ||||||
| 04/03/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: HIV | ||||||
| 03/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Respiratory | ||||||
| 10/27/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ANTIBIOTIC | ||||||
| 10/25/2023 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: HIV | ||||||
| 09/21/2023 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: VACCINES | ||||||
| 09/14/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/26/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $101.56 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 06/01/2023 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $5.95 | General |
| Category: Respiratory | ||||||
| 05/11/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ANTIBIOTIC | ||||||
| 02/21/2023 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: HIV | ||||||
| 12/08/2022 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Infectious Diseases | ||||||
| 12/06/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/20/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/04/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 06/16/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ANTIBIOTIC | ||||||
| 06/09/2022 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Infectious Diseases | ||||||
| 06/02/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 748 | 1,402 | $251,370 | $106,515 |
| 2022 | 6 | 846 | 1,598 | $289,779 | $114,903 |
| 2021 | 6 | 822 | 1,701 | $299,080 | $120,831 |
| 2020 | 7 | 820 | 1,643 | $294,155 | $119,433 |
Total Patients
3,236
Total Services
6,344
Medicare Billing
$461,681
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 172 | 394 | $78,800 | $36,116 | 45.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 457 | $63,523 | $28,087 | 44.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 171 | 185 | $49,210 | $18,501 | 37.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 95 | $36,955 | $12,639 | 34.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 144 | 253 | $19,228 | $9,695 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 18 | $3,654 | $1,477 | 40.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 226 | 542 | $108,400 | $43,091 | 39.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 164 | 427 | $59,353 | $23,756 | 40.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 119 | 124 | $48,236 | $18,697 | 38.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 161 | 173 | $46,018 | $18,154 | 39.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 163 | 312 | $23,712 | $9,394 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 20 | $4,060 | $1,812 | 44.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 201 | 440 | $88,000 | $35,643 | 40.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 178 | 611 | $84,929 | $34,575 | 40.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 181 | 194 | $51,604 | $20,337 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 110 | $42,790 | $17,271 | 40.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 139 | 303 | $23,028 | $9,204 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 43 | $8,729 | $3,801 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 208 | 721 | $101,317 | $41,650 | 41.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 184 | 382 | $77,084 | $31,424 | 40.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 265 | 280 | $74,609 | $30,461 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 39 | $15,273 | $6,256 | 41.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 91 | 160 | $12,240 | $5,043 | 41.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 44 | $8,954 | $3,066 | 34.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 17 | $4,678 | $1,532 | 32.8% |
About Dr. Gerardo Negron, MD
Dr. Gerardo Negron, MD is a Infectious Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396795795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerardo Negron, MD has received a total of $10,209 in payments from pharmaceutical and medical device companies, with $135.03 received in 2024. These payments were reported across 149 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,000).
As a Medicare-enrolled provider, Negron has provided services to 3,236 Medicare beneficiaries, totaling 6,344 services with total Medicare billing of $461,681. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Shreveport, LA
- Active Since 05/10/2006
- Last Updated 02/15/2011
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1396795795
Products in Payments
- VIBATIV (Drug) $6,957
- Arikayce (Drug) $454.88
- SYMTUZA (Drug) $267.81
- ISENTRESS (Drug) $178.38
- PREZCOBIX (Drug) $174.11
- Baxdela (Drug) $160.24
- Cresemba (Drug) $158.95
- Genvoya (Drug) $125.00
- Biktarvy (Drug) $114.99
- JULUCA (Drug) $95.24
- Symtuza (Drug) $93.75
- MYCAMINE (Drug) $84.49
- NUZYRA (Drug) $76.94
- EGRIFTA (Drug) $69.94
- ZERBAXA (Drug) $69.04
- TRIUMEQ (Drug) $63.63
- CRESEMBA (Drug) $47.69
- Orbactiv (Drug) $44.80
- ORBACTIV (Drug) $39.92
- PREVNAR 20 (Biological) $36.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Shreveport
Guillermo Padilla, M.d, M.D
Infectious Disease — Payments: $186,696
Infectious Disease $186,696
Jihad El-Hayek, M.d, M.D
Infectious Disease — Payments: $13,949
Infectious Disease $13,949
Dr. Mohammad Alam, Md, MD
Infectious Disease — Payments: $3,936
Infectious Disease $3,936
John Todd, M.d, M.D
Infectious Disease — Payments: $3,715
Infectious Disease $3,715
Raymond Coghlan, Md, MD
Infectious Disease — Payments: $850.28
Infectious Disease $850.28
John King, M.d, M.D
Infectious Disease — Payments: $63.78
Infectious Disease $63.78